Clinical trial
Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C
NCT00209755 · Hopital A Michallon, Other · Terminated
Key facts
| NCT number | NCT00209755 |
|---|---|
| Title | Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C |
| Official title | Diagnostic Value of Plasma Ribavirin Assay During the Combination Therapy " Pegylated Interferon + Ribavirin " in Chronic Hepatitis C. |
| Lead sponsor | Hopital A Michallon, Other |
| Collaborators | University Hospital, Grenoble Central Hospital, Nancy, France |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Procedure |
| Interventions | therapeutic drug monitoring of ribavirin and dose adaptation |
| Enrollment | 40 |
| Start date | Oct 1, 2003 |
| Completion | Jul 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 21, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: